Subscribe to the World's Most Popular Newsletter (it's free!)
To confidently diagnose and treat
Lyme disease, the clinician must first understand the natural history of this
disease, especially its protean early manifestations. Emergency physicians, primary care physicians, and other providers need to be vigilant in terms of the timely recognition of erythema migrans (EM), the unique marker of early localized stage 1
disease. The classic EM, originally described as a slowly expanding bull’s eye lesion, is now recognized to be present in only the minority of cases (9%); the dominant morphologic lesion of EM is now recognized to be the diffusely homogenous red plaque or patch, which occurs in over 50% of cases. This update will define the current morphologic features of early
Lyme disease, the indication for serologic studies, and the most recent treatment guidelines, including therapeutic pitfalls.
Copyright © 2010 Elsevier Inc. All rights reserved.